Literature DB >> 21886757

Respiratory function in patients with pemphigus vulgaris - a small clinical study.

Zoi Apalla1, Diamantis Chloros, Paraskevi Argyropoulou, Dimitrios Georgopoulos, Dimitrios Patakas, Dimitrios Spanos, George Chaidemenos.   

Abstract

BACKGROUND: Pemphigus vulgaris belongs to a group of rare, autoimmune, blistering disorders, requiring intensive immunosuppressive therapy. Lung infections are common in patients with pemphigus vulgaris.
OBJECTIVE: To evaluate pulmonary function in patients with pemphigus vulgaris, in order to detect possible factors that might predispose PV patients to lung damage.
METHODS: Ten patients first diagnosed with severe pemphigus vulgaris and 10 healthy individuals,were included in the study. Pulmonary function testing, blood gas analysis and quantification of α1-antitrypsin serum levels were performed.
RESULTS: Mild reduction of CO diffusing capacity was recorded, compared to the mean predicted normal value. DLCOSB (single-breath carbon monoxide diffusing capacity test) values did not significantly differ between patients with pemphigus vulgaris and healthy controls, while differences regarding DLCO/VA (VA: Alveolar Volume) were statistically significant. Alpha 1-antitrypsin serum levels were decreased (<2.0g/L) in 60% (6/10) of patients with pemphigus vulgaris and were found normal in none of the healthy controls.
CONCLUSION: A mild reduction of pulmonary diffusing capacity was observed in patients with pemphigus vulgaris.

Entities:  

Keywords:  alpha 1-antitrypsin; lung; pemphigus; pemphigus vulgaris; respiratory failure

Year:  2011        PMID: 21886757      PMCID: PMC3163349          DOI: 10.3315/jdcr.2011.1061

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  10 in total

1.  The mechanism of respiratory failure in paraneoplastic pemphigus.

Authors:  H C Nousari; R Deterding; H Wojtczack; S Aho; J Uitto; T Hashimoto; G J Anhalt
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

2.  Rituximab in autoimmune bullous diseases: mixed responses and adverse effects.

Authors:  E Schmidt; C S Seitz; S Benoit; E B Bröcker; M Goebeler
Journal:  Br J Dermatol       Date:  2007-02       Impact factor: 9.302

3.  Defining the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease.

Authors:  Nicola Cirillo; Michele Lanza; Luigi Rossiello; Fernando Gombos; Alessandro Lanza
Journal:  J Cell Physiol       Date:  2007-07       Impact factor: 6.384

4.  Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.

Authors:  V T Nguyen; A Ndoye; K D Bassler; L D Shultz; M C Shields; B S Ruben; R J Webber; M R Pittelkow; P J Lynch; S A Grando
Journal:  Arch Dermatol       Date:  2001-02

5.  Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission.

Authors:  Lindsay C Strowd; Sarah L Taylor; Joseph L Jorizzo; Mohammad R Namazi
Journal:  J Am Acad Dermatol       Date:  2010-07-14       Impact factor: 11.527

6.  Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency.

Authors:  Jayne Holme; Robert A Stockley
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

7.  IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.

Authors:  Ralf Müller; Vera Svoboda; Elke Wenzel; Hans-Helge Müller; Michael Hertl
Journal:  Exp Dermatol       Date:  2008-01       Impact factor: 3.960

8.  Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.

Authors:  Yuan-Ping Han; Chunli Yan; Warren L Garner
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

9.  The specific proteolysis hypothesis of pemphigus: does the song remain the same?

Authors:  Nicola Cirillo; Antonio Dell' Ermo; Fernando Gombos; Alessandro Lanza
Journal:  Med Hypotheses       Date:  2007-07-26       Impact factor: 1.538

10.  Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.

Authors:  Malgorzata Olszewska; Zofia Kolacinska-Strasz; Jadwiga Sulej; Hanna Labecka; Jaroslaw Cwikla; Urszula Natorska; Maria Blaszczyk
Journal:  Am J Clin Dermatol       Date:  2007       Impact factor: 7.403

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.